10x Genomics, Inc.
TXG
$9.42
$0.313.40%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 40.58% | 28.41% | 18.27% | -39.17% | -51.61% |
| Total Depreciation and Amortization | -9.61% | 0.20% | 11.06% | 22.76% | 38.19% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -21.89% | -19.34% | -10.09% | -3.13% | 11.15% |
| Change in Net Operating Assets | 110.70% | -92.77% | 203.29% | 150.63% | 151.87% |
| Cash from Operations | 311.74% | 143.85% | 243.84% | 32.34% | -58.29% |
| Capital Expenditure | 75.77% | 74.50% | 84.54% | 76.96% | 56.56% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -147.50% | -111.11% | -74.12% | -59.32% | -48.73% |
| Cash from Investing | -286.84% | -124.44% | -63.24% | -18.34% | -9.23% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | 100.00% | 100.00% | 100.00% |
| Issuance of Common Stock | -48.20% | -43.98% | -36.36% | -1.86% | 18.49% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -48.20% | -20.16% | -8.02% | 51.35% | 87.47% |
| Foreign Exchange rate Adjustments | 98.10% | -396.97% | 29.08% | -141.84% | -5,150.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 33.11% | -111.53% | 13.98% | -0.19% | -18.77% |